When looking at countries from which data from ≥3 CoEs were available, the Netherlands was most limited in the periodic screening of GN‐MEN1 patients, with three out of four CoEs indicating periodic screening would depend on the clinical characteristics of the patient and no periodic follow‐up would be advised for 1st degree family members (Figure S7). The gene discussed is MEN1; the disease is ganglioneuroma.